|When: Wednesday, September 23rd from 8:00 to 10:00 AM
Join Our Clients:
|Against a backdrop of regulatory pressure, M&A activity, drug commercialization obstacles, rising R&D costs, and shrinking R&D pipelines – FP&A teams at high growth life sciences companies face a variety of challenges when it comes to strategic planning, budgeting and forecasting.
Attend this exclusive, invitation-only breakfast event to hear how Cervello clients Momenta Pharmaceuticals and Merrimack Pharmaceuticals, have re-imagined their FP&A processes and approach to technology in light of these very challenges.
Hear how they are using Cloud EPM technology as a catalyst for achieving financial excellence and to becoming a strategic, value-added partner to the business.
At this event you’ll: